MedTrace Logo

Validation of a Contactless Vital Signs Measurement Sensor

NCT04676191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-01-25

No results posted yet for this study

Summary

The primary aim of this study is to validate the performance of Sleepiz One+ for the measurement of vital physiological parameters in adult population, against a laboratory-based polysomnography. Additionally, the investigators will evaluate Sleepiz One+ ability to identify patients with a high risk of suffering from a sleep-related breathing disorder based on apnea-hypopnea index estimation. Participants will undergo measurement with Sleepiz One+ and a polysomnography device while resting in bed for 20 min as well as during sleep for the duration of the following night.

Conditions

Interventions

DEVICE

Sleepiz One+

Simultaneous sleep study with polysomnography and Sleepiz One+

DEVICE

Polysomnography

Simultaneous sleep study with polysomnography and Sleepiz One+

Sponsors & Collaborators

  • Sleepiz AG

    lead INDUSTRY

Principal Investigators

  • Bartosz Bujan, Dr. med. · Klinik Lengg, Zurich

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-10
Primary Completion
2021-02-02
Completion
2022-01-12

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04676191 on ClinicalTrials.gov